key: cord-1020446-yz6e8so4
authors: Higgins, Christina A.; Nilsson-Payant, Benjamin E.; Kurland, Andrew P.; Adhikary, Prithy; Golynker, Ilona; Danziger, Oded; Panis, Maryline; Rosenberg, Brad R.; tenOever, Benjamin; Johnson, Jeffrey R.
title: SARS-CoV-2 hijacks p38ß/MAPK11 to promote viral protein translation
date: 2021-08-20
journal: bioRxiv
DOI: 10.1101/2021.08.20.457146
sha: acc0dfbfe9ffd6820b3080ae5401345480bb80df
doc_id: 1020446
cord_uid: yz6e8so4

SARS-CoV-2, the causative agent of the COVID-19 pandemic, drastically modifies the cells that it infects. One such effect is the activation of the host p38 mitogen-activated protein kinase (MAPK) pathway, which plays a major role in inflammation pathways that are dysregulated in severe COVID-19 cases. Inhibition of p38/MAPK activity in SARS-CoV-2-infected cells reduces both cytokine production and viral replication. Here, we applied a systems biology approach to better understand interactions between the p38/MAPK pathway and SARS-CoV-2 in human lung epithelial cells. We found several components of the p38/MAPK pathway positively and negatively impact SARS-CoV-2 infection and that p38ß is a required host factor for SARS-CoV-2 that acts by promoting viral protein translation in a manner that prevents innate immune sensing. Furthermore, we combined chemical and genetic perturbations of p38ß with quantitative phosphoproteomics to identify novel, putative p38ß substrates in an unbiased manner, with broad relevance beyond SARS-CoV-2 biology.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 37 2019 (COVID-19) pandemic, has caused millions of deaths worldwide since it emerged in late 2019. While 38 vaccines are highly effective at preventing severe illness and death, novel SARS-CoV-2 variants are 39 continuously emerging with increased transmissibility and pathogenicity and it is possible that vaccines may be 40 less effective against variants that arise in the future. Currently, only two drug therapies have proven efficacious 41 for COVID-19 treatment: remdesivir, a nucleoside analog that targets the viral polymerase and provides a modest 42 reduction in recovery time compared to placebo (Grein et al., 2020) , and dexamethasone, a synthetic 43 glucocorticoid with potent anti-inflammatory properties that reduced COVID-19 deaths by a third in ventilated 44 patients and by a fifth for patients receiving supplemental oxygen (Grein et al., 2020; Group et al., 2020 ). An 45 anti-inflammatory monoclonal antibody treatment targeting the IL-6 receptor, tocilizumab, has been the subject of two clinical trials for COVID-19 treatment, but was not found to improve survival in either (Rosas et al., 2021;  47 Salama et al., 2021) . It is therefore imperative to continue to identify targets for COVID-19 therapeutic 48 development to improve outcomes for severe COVID-19 cases.

Severe COVID-19 cases are associated with excessive inflammation in the lung that can lead to acute 50 respiratory distress syndrome, respiratory failure, multi-organ failure, and death (Mehta et al., 2020; Merad and 51 Martin, 2020) . We previously reported in a phosphoproteomics study of SARS-CoV-2 infection that the p38 52 mitogen-activated protein kinase (MAPK) pathway becomes activated during infection and that inhibition of p38 53 reduces both inflammatory cytokine expression and SARS-CoV-2 replication, suggesting that p38 inhibition may 54 target multiple mechanisms related to SARS-CoV-2 pathogenesis (Bouhaddou et al., 2020) . While the 55 mechanisms by which the p38/MAPK pathway regulates inflammatory cytokine gene expression and RNA 56 stability are well described, the mechanism by which p38/MAPK inhibition reduces SARS-CoV-2 replication is 57 unknown. Furthermore, the p38/MAPK pathway is comprised of four p38 kinase isoforms (p38α, p3β, p38γ, and 58 p38δ) and at least six downstream effector kinases (MAPKAPK2, MAPKAPK3, MAPKAPK5, MSK1, MSK2, and 59 MKNK1), but it is not known which kinases at which levels of the p38/MAPK pathway impact SARS-CoV-2 60 replication ( Roux and Blenis, 2004) .

Here we combined siRNA screening, chemical and genetic perturbations, and quantitative proteomics to 62 better understand interactions between the p38/MAPK pathway and SARS-CoV-2 in infected cells. We identified 63 p38ß as an essential host factor for SARS-CoV-2 replication and found that p38 inhibition reduced viral protein 64 levels but did not impact viral mRNA levels. We applied an unbiased hierarchical clustering approach to identify enrichment analysis (GSEA) approach with kinase-substrate annotations derived from the PhosphoSite Plus 02 resource (Beltrao et al., 2012; Hornbeck et al., 2015; Subramanian et al., 2005) . Kinase activity profiles for data 03 collected in human cell lines were strongly correlated, while profiles derived from A549 cells were somewhat 04 anticorrelated with data collected in Vero E6 cells, and there was a modest correlation between data collected 05 in Caco-2 and Vero E6 cells ( Figure S1B , Table S2 ). This analysis identified GSK3B, ATR, p38ɑ, MAPKAPK2, 06 ABL, AMPKA1, mTOR, ATM, PLK1, and AURKB as the ten most commonly regulated kinases among all 07 characterized kinases across the data sets examined ( Figure 1E and Figure S1E ). Kinases involved in cell cycle 08 arrest -ATM, PLK1, and AURKB -were consistently regulated across all data sets, consistent with findings that 09 SARS-CoV-2 infection leads to cell cycle arrest (Bouhaddou et al., 2020) . Of particular interest to this study, the 10 MAP kinase p38ɑ and its downstream kinase, MAPKAPK2/MK2, were significantly regulated in all human studies 11 and in several time points of the Vero E6 study. Inspection of the log2fold-change profiles of individual substrates 12 that contributed to each kinases' enrichment signals (the "leading edge" subset) revealed substrates that are 13 commonly and differentially regulated across data sets ( Figure 1F , Figure S1C , and Table S1 ). For p38ɑ 14 substrates, HSPB1/Hsp27 and BAZ1B were observed with increased phosphorylation in every data set collected 15 thus far, while increased phosphorylation of other p38ɑ substrates such as EGFR, ATF2, and MK2 was only 16 detected in studies in human cell lines ( Figure 1F ; Table S4 ). Gene ontology enrichment analysis of log2fold-17 change profiles of protein and phosphorylation group changes from all studies revealed similarities between Vero 18 E6 and Caco-2 cells for downregulation of proteins in extracellular localizations. Caco-2 cells uniquely increased 19 proteins in type I interferon signaling pathway ontology terms ( Figure S1E , Table S3 ). 

Higgins et al.

A549-ACE2 cells were transfected with siRNA pools targeting genes of interest, infected with SARS-CoV-2 for 30 36 hours, stained for SARS-CoV-2 nucleocapsid protein (N), and the percent cells infected was determined by 31 immunofluorescence imaging cytometry. We identified p38ß as an essential host factor for SARS-CoV-2 32 infection, with approximately 90% reduction in infected cells and three log-fold reduction in virus titers when p38ß 33 was knocked down compared to a non-targeting control ( Figure 2B-C) . Surprisingly, knockdown of p38ɑ did not 34 affect the percent of N-positive cells even though p38ɑ and p38ß are often presumed to be functionally 35 redundant. We also found that p38δ knockdown reduced infection by approximately 40% and that p38γ 36 knockdown increased infection by approximately 50% (Figure 2B -C). Based on RNAseq analysis, p38ɑ was 37 expressed the highest in A549-ACE2 cells followed by p38γ, p38ß, and p38δ ( Figure S2A ). Of the downstream 38 effector kinases, we found that only MSK2 knockdown reduced viral infection by approximately 65% ( Figure 2B -39 C). We confirmed efficient siRNA knockdown of p38ɑ, p38ß, p38γ, and MSK2 protein expression by western 40 blotting ( Figure 2D ). We also verified that siRNA transfections did not affect cell viability for each of the siRNA 41 pools ( Figure S2B ). Focusing next on upstream regulation of the p38/MAPK pathway, we again used siRNA 42 screening to assess the effects of individual MAPKKK and MAPKK knockdown on viral infection. Among the 43 MAPKKKs screened, we found that MAP3K8/TPL2/COT, MAP3K9/MLK1, and MAP3K11/MLK3 knockdown 44 reduced SARS-CoV-2 infection by approximately 70%, 95%, and 80%, respectively, while 45 MAP3K17/TAOK2/PSK knockdown increased infection by nearly 100% ( Figure 2E ). Cell viability was again not 46 affected by siRNA transfection ( Figure S2A ). Finally, we confirmed by plaque assays significant reductions in 47 virus titer upon MAP3K8, MAP3K9, and MAP3K11 knockdown ( Figure 2F ).

p38ß proviral mechanism is primarily STAT1-independent but leads to ISG expression as a byproduct 50 51 Given that the p38/MAPK pathway is known to regulate the gene expression and mRNA stability of many genes, 52 we hypothesized that the proviral MAPK/p38 pathway kinases, p38ß, p38δ, and MSK2 may promote the 53 expression of a host factor required for SARS-CoV-2 replication. We therefore assessed how siRNA knockdown 54 of p38ß, p38δ, or MSK2 in the context of SARS-CoV-2 infection affects the host proteome during infection using 55 quantitative proteomics. In biological quadruplicate, A549-ACE2 cells were transfected with siRNA pools 56 targeting non-targeting control, p38ß, p38δ, or MSK2. Cells were then infected with SARS-CoV-2 at an MOI of 0.1, or mock-infected. At 36 hours post-infection, cells were lysed and subjected to trypsin digestion, Fe 3+ -IMAC 58 phosphopeptide enrichment, and DIA-MS analysis as described previously ( Figure 3A ). A total of 4,900 unique 59 protein groups and 14,414 unique phosphorylation site groups were identified in these experiments ( Figure 3B ).

These data clustered by their respective siRNA targets in both principal component and Pearson correlation 61 analysis and each sample has similar log2intensities ( Figure S3A -F). In comparison to non-targeting 62 control/mock-infected cells, non-targeting control/SARS-CoV-2-infected cells yielded few changes to the 63 proteome and large changes to the phosphoproteome with approximately 1,000 phosphorylation site groups 64 significantly increasing and decreasing. Knockdown of each kinase in SARS-CoV-2-infected cells led to more 65 substantial changes to the proteome. Compared to non-targeting control/SARS-CoV-2-infected cells, knockdown 66 of p38ß, p38δ, or MSK2, led to 287, 141, and 355 unique protein groups significantly increasing, respectively, 67 and 274, 201, and 122 protein groups significantly decreasing compared to non-targeting control/mock-infected 68 cells, respectively. There were also significant changes to the phosphoproteome in response to each of the 69 kinase knockdowns, in comparison to non-targeting control/infected. Knockdown of p38ß, p38δ, or MSK2, led to 70 75, 842, and 474 unique phosphorylation site groups significantly increasing, respectively, and 339, 768, and 71 624 phosphorylation site groups significantly decreasing, respectively ( Figure 3C , Table S1 ). Gene ontology 72 enrichment analysis of protein abundance log2fold-change profiles revealed that SARS-CoV-2 infected cells with 73 siRNA-suppressed levels of p38ß or p38δ exhibited a strong type I interferon signature compared to infected 74 cells transfected with a non-targeting control. In contrast, MSK2 knockdown in SARS-CoV-2-infected cells did 75 not lead to a comparable type I interferon signature, further suggesting MSK2 is primarily not responsible for the 76 p38ß phenotype ( Figure 3D , Table S5 ). Looking specifically at well-characterized, anti-viral interferon-stimulated 77 genes (ISGs), most were more upregulated in response to p38ß or p38δ knockdown in SARS-CoV-2-infected 78 cells compared to non-targeting control SARS-CoV-2 infected cells ( Figure 3E ) (Schoggins and Rice, 2011).

Western blotting confirmed that p38ß knockdown in SARS-CoV-2-infected cells led to an increase in MX1, a 80 prototypical ISG ( Figure S3G ).

These findings led us to question whether p38ß knockdown reduced SARS-CoV-2 replication by leading 82 to the expression of ISGs that restrict viral replication, or if p38ß knockdown reduced viral replication in a primarily 83 ISG-independent manner that incidentally led to the expression of ISGs, for example, by exposing a pathogen-84 associated molecular pattern (PAMP) that is sensed by the innate immune system. To address this, we 8 compared SARS-CoV-2 infection and p38ß, p38δ, or MSK2 siRNA knockdown in A549-ACE2 cells to STAT1-86 knockout A549-ACE2 cells which are unable to activate STAT1-dependent ISG expression. If STAT1-dependent 87 expression of ISGs is required to restrict infection in cells with reduced p38ß/δ expression, deletion of STAT1 88 will restore SARS-CoV-2 replication to wild-type levels. We found that the reduction in SARS-CoV-2 infection in 89 p38ß, p38δ, or MSK2 siRNA-transfected cells is not appreciably rescued by STAT1-knockout, indicating that the 90 mechanisms of action of these p38/MAPK pathway kinases are primarily ISG-and STAT1-independent ( Figure   91 3F-G). We confirmed by Western blotting STAT1 knockout and ablation of MX1 expression as well as STAT1 92 phosphorylation in the A549ΔSTAT1-ACE2 cells, and efficient knockdown of the kinases of interest by siRNA 93 transfection ( Figure 3G ). These findings demonstrate that the interferon signature caused by p38ß and p38δ 94 knockdown is not the primary mechanism by which p38 inhibition reduces SARS-CoV-2 infection.

Quantitative phosphoproteomics identifies novel p38ß substrates in an unbiased manner 97 98

We next sought to better understand how the host phosphoproteome of SARS-CoV-2-infected cells changes in 99 response to p38 inhibition to identify putative p38ß substrates that may explain the mechanism by which it 00 reduces SARS-CoV-2 infection. We employed three strategies to identify p38ß substrates: (1) siRNA knockdown 01 of p38ß (described above); (2) titration of a p38ɑ/ß inhibitor, SB203580, for 1 hour preceding SARS-CoV-2 02 infection for 24 hours (pre-treatment), and (3) infection with SARS-CoV-2 for 24 hours with the last 4 hours of 03 infection in the presence of SB203580 treatment (terminal treatment). We selected the p38 inhibitor SB203580 04 as it is well-characterized and specific for p38ɑ/ß (Cuenda et al., 1995) . In all cases, cells were lysed and 05 subjected to proteome and phosphoproteome analysis as described previously ( Figure 4A ). These data clustered 

CoV-2 infected, SB203580 terminally treated compared to SARS-CoV-2 infected, DMSO terminally treated conditions, with only 23 and 145 phosphopeptide groups significantly increased and decreased, respectively. As 14 for the pre-treatment observations, 98, 54, and 30 phosphopeptide groups differentially increased and 33, 123, 15 and 68 phosphopeptide groups differentially decreased, in SARS-CoV-2 infected/DMSO treated fold over mock-16 infected/DMSO-treated, infected/1μM SB203580-treated fold over infected/DMSO-treated, and infected/10μM 17 SB203580-treated fold over infected/DMSO-treated, respectively ( Figure 1C , Table S1 ). We observed a 18 significant decrease in phosphorylation of known p38 substrates, CP131 at S47, HSPB1 at S15, PARN at S557,

RIPK1 at S320, in response to SB203580 in both pre-treatment and terminal treatment experiments, which 20 confirmed effectiveness of the drug treatment with both approaches ( Figure S4G and S4O). We combined these 21 phosphoproteome profiles with p38ß knockdown profiles and developed an unbiased hierarchical clustering 22 approach to identify novel, putative p38ß substrates. First, log2fold-change profiles were hierarchically clustered 23 based on their Euclidian distances ( Figure 4D ). Any profiles with missing values in any condition were excluded 24 from this analysis. The data subjected to hierarchical clustering contained 1,191 phosphorylation profiles in total 25 and 12 phosphorylation profiles annotated in Phosphosite Plus to be substrates of p38α, p38ß, or one of their 26 downstream effector kinases (i.e., MK2, MK3, MK5, MSK1, MSK2, or MKNK1) (Hornbeck et al., 2015) . The data 27 were then clustered into 2 to 100 clusters by cutting the dendrogram tree in order of decreasing height, and for 28 each iteration the significance of enrichment of p38α/ß substrates in each cluster was calculated by a 29 hypergeometric test. The best enrichment of p38α/ß substrates was achieved when the data were separated 30 into 3-12 clusters ( Figure 4E ). The cluster most significantly enriched for p38α/ß substrates occurred in iterations 31 3-12 and contained 35 phosphorylation sites in total with 3 annotated p38α/ß substrates (HSPB1, RBM7, and 32 TIF1B; hypergeometric p-value = 0.005) ( Figure 4F , Table S6 ). This group of novel, putative p38ß substrates 33 includes several annotated p38α/ß substrates at phosphorylation positions not annotated as p38α/ß-dependent 34 (TIF1B, HSPB1, NELFE), and proteins physically associated with annotated p38α/ß substrates (LARP7, TIF1A) 35 ( Figure 4G ). This cluster is enriched for processes commonly associated with the p38/MAPK pathway, including 36 RNA binding, protein folding, and transcription elongation ( Figure 4G In addition to identifying novel host p38 substrates, we also explored possible p38-dependent phosphorylation 41 of SARS-CoV-2 proteins. In order to focus on viral phosphorylation sites, we specifically looked at the short, 42 terminal drug treatment dataset because the short drug treatment is effective at inhibiting p38α/ß kinases but 43 does not affect total viral protein abundance. This allowed us to accurately quantify changes to viral 44 phosphorylation sites in response to p38 inhibition independent of viral protein abundance. In our analyses, 45 SARS-CoV-2 N was the only viral protein identified with significantly changing p38-dependent phosphorylation 46 sites based on p-values, although the fold-changes were less than the 2-fold threshold we implemented 47 throughout this study. Four identified phosphosites (S21, S23, T24, and S26) significantly decreased during 48 infection in response to SB203580 compared to DMSO treatment ( Figure 5A 

To further elucidate the mechanism of action responsible for the proviral behavior of p38ß, we performed 55 a high MOI, single cycle infection with SARS-CoV-2 in A549-ACE2 cells transfected with non-targeting or p38ß 56 siRNA, and analyzed host and viral mRNA using next-generation sequencing. We compared SARS-CoV-2 57 genomic RNA coverage by considering the number of viral reads at each nucleotide position and observed that 58 there was no significant difference in genome coverage comparing cells infected and treated with siRNA 59 targeting p38ß compared to control, suggesting p38ß does not play a role in regulating genomic RNA replication 60 versus subgenomic RNA transcription ( Figure 5C) . Surprisingly, percentage viral reads did not change between 61 cells infected and transfected with non-targeting control siRNA compared to p38ß siRNA, even though p38ß 62 protein expression was significantly reduced ( Figure 5D ), and previous data showed drastic decrease in viral 63 replication during multicycle infections with p38ß knockdown ( Figure 2B -C, Table S7 ). GO term enrichment 64 analysis of differential gene expression data from p38ß siRNA transfected over non-targeting control siRNA 65 transfected infected cells supports previous findings including the upregulation of type I interferon signaling 66 ( Figure 5E , Table S8 ). GO term enrichment analysis of SARS-CoV-2 infected, control transfected fold over mock-67 infected, control transfected gene expression data revealed upregulation of MAPK signaling pathway regulation and extracellular matrix organization, supporting previous findings ( Figure S5C , Table S9 ). To further assess 69 SARS-CoV-2 replication in a single-cycle setting, viral subgenomic mRNA, genomic mRNA, and protein levels 70 were measured after a high MOI, single-cycle infection with SARS-CoV-2 in A549-ACE2 cells transfected with 71 siRNA targeting p38/MAPK members. Again, there was no significant difference in genomic RNA abundance 72 (i.e. nsp14) compared to subgenomic mRNA abundance (i.e. trs-N and trs-S) with p38ß inhibition compared to 73 non-targeting control. Also, normalized to SARS-CoV-2 infected cells transfected with non-targeting control 74 siRNA, knockdown of SARS-CoV-2 N resulted in similar decreases in N-positive cells and viral transcript 75 expression, but knockdown of p38ß resulted in significant decrease in N-positive cells, but no significant change 76 in viral transcript abundance ( Figure 5F ). These findings suggest the proviral activity of p38ß promotes viral 77 protein translation.

In this study, we systematically characterized the p38/MAPK pathway in the context of SARS-CoV-2 infection 81 using a combination of genetics, genomics, and proteomics approaches. We identified the specific segments of 82 the p38/MAPK pathway that impact SARS-CoV-2 infection and discovered p38/MAPK substrates in an unbiased 83 manner. We found that p38ß is the major component of the p38/MAPK pathway contributing to SARS-CoV-2 84 infection and that it does so at the stage of viral protein translation. These findings inform on basic SARS-CoV-85 2 biology, identify novel drug targets for the treatment of COVID-19, and provide a methodological approach for 86 the identification of kinase substrates that can be broadly applied to many areas of research. shown to potently activate the p38 pathway, but it is not known whether these activities are conserved for SARS-

CoV-2 (Jimenez- Guardeno et al., 2014; Kopecky-Bromberg et al., 2006) . In vivo, SARS-CoV-2 infection leads 95 to the production of an inflammatory cytokine signature that includes IL-6 and TNFɑ, which are well documented to activate the p38/MAPK pathway (Karki et al., 2021) . In the present study, we show that knockdown of 97 MAP3K8, MAP3K9, or MAP3K11 significantly inhibited SARS-CoV-2 infection in a manner similar to p38 98 inhibition. This was surprising as MAPKKKs are generally thought to be more functionally redundant, but these 99 data suggest that specific MAPKKKs contribute to p38/MAPK pathway signal transduction in the context of 00 SARS-CoV-2 infection. Given that MAPKKKs are typically activated by G-protein coupled receptors associated 01 with receptors on the cell surface, such as cytokine receptors, we favor a model whereby the p38/MAPK pathway 02 becomes activated as a result of cytokine production, but alternative mechanisms are plausible. and preventing enzymatic activity, primarily inhibiting p38ɑ and p38ß as they have larger pockets than p38γ and 08 p38δ (Han et al., 2020). They were widely used to characterize the p38 kinases prior to the advent of genetic 09 perturbation approaches like RNAi and CRISPR. As p38ɑ and p38ß have 75% sequence similarity between 10 them, these two isoforms have been generally presumed to be functionally redundant. However, pyridinyl 11 imidazole class inhibitors are ten-fold more effective at inhibiting p38ɑ than p38ß. Many phosphorylation sites 12 annotated as p38ß substrates were identified using these inhibitors and thus would benefit from further 13 inspection with modern genetic or chemical biology approaches such as analog-sensitive kinase inhibition.

14 Additionally, there are documented functional differences between p38ɑ and p38ß. p38ɑ knockout mice are 15 embryonically lethal whereas p38ß knockout mice are viable and fertile (Beardmore et al., 2005) . p38ß has also 16 been shown to be uniquely capable of auto-phosphorylation (Beenstock et al., 2016) . In the present study, we 17 show p38ß, but not p38ɑ, is required for SARS-CoV-2 replication in human lung epithelial cells. These data, in 18 addition to other p38ß-focused research, emphasize the need for p38ß-specific inhibitors and reagents to help 19 better characterize this isoform. p38ß does not appear to be essential and it has a distinctly smaller active site 20 than p38ɑ that may allow for the development of specific inhibitors, thus we believe p38ß may make an attractive We globally quantified changes to the phosphoproteome in response to several perturbations affecting 27 p38/MAPK signal transduction including a pretreatment with two concentrations of p38 inhibitor before SARS-

CoV-2 infection, a short treatment with p38 inhibitor in the last 4 hours of SARS-CoV-2 infection, and p38 isoform 29 knockdown by siRNA before SARS-CoV-2 infection. In combination, these data allowed us to extract log2fold-30 change profiles of annotated p38 substrate phosphorylation sites in response to these perturbations and to 31 identify novel, putative p38ß substrates based on the similarity of their profiles to annotated p38 substrate 32 profiles. We developed a hierarchical clustering approach and an unbiased method to determine the optimal 33 number of clusters. This approach is broadly applicable for kinases for which some annotated substrates have 34 been identified and for which specific inhibitors are available. It could be advantageous to perturb the system 35 with multiple inhibitors, inhibitor concentrations, or time points to separate off-and on-target inhibitor effects and 36 to develop more specific substrate profiles to feed into the clustering algorithm. One limitation of this approach 37 is that it cannot determine whether the substrates identified were direct substrates of the kinase of interest. 

Additionally, phosphorylation of Betacoronavirus murine hepatitis virus (MHV) N by GSK-3 has been shown to 47 regulate replication of genomic RNA versus subgenomic RNA by promoting template read-through (Wu et al., 48 2014) . In this study, we identified phosphosites on SARS-CoV-2 N that were p38-dependent, although their fold-49 changes were more modest compared to that of host p38 substrates that were quantified. As N phosphorylation 50 is known to affect its activity, it is plausible that p38-dependent N phosphorylation is responsible for the 51 phenotypes we observed, but we cannot exclude the possibility that p38-dependent phosphorylation of a host protein may drive these phenotypes. Further experiments are required to determine the impact of novel p38ß 53 phosphorylation substrates on SARS-CoV-2 infection. 54 55 p38ß promotes translation of viral proteins 56 57 p38 pathway signal transduction promotes MHV protein translation by acting through p38ɑ/ß-mediating kinase, 58 MKNK1, in order to promote cap-dependent translation by phosphorylating eIF4E (Banerjee et al., 2002) . Our 59 data also suggest that p38ß activity promotes coronavirus protein translation, however, here we show 60 knockdown of MKNK1 has no effect on SARS-CoV-2 protein expression ( Figure 2B ). Reduced mRNA cap 

An MS scan at 60,000 resolving power over a scan range of 390-1010 m/z, an instrument controlled AGC target, 38 an RF lens setting of 30%, and an instrument controlled maximum injection time, followed by DIA scans using 8 39 m/z isolation windows over 400-1000 m/z at a normalized HCD collision energy of 28%. 

Genome schematic was created with BioRender (BioRender.com).

Mass spectrometry data analysis 38 All raw mass spectrometry data generated in this study were analyzed by the Spectronaut software suite protein N-terminal acetylation. We added variable modifications for serine/threonine/tyrosine phosphorylation 44 for phosphoenriched samples. All DDA-MS runs generated in this study were combined to make one spectral library against which all DIA-MS data were analyzed. DIA-MS data were also analyzed by Spectronaut to 46 extract fragment ion intensity information based on the spectral library described above using Biognosys 47 factory settings. The data were exported as a tab-delimited, MSstats-formatted report. 

Unbiased identification of p38β substrates For hierarchical clustering, comparison indicated in Figure 4 were first filtered missing logfold-change values in 69 any condition. Distances were calculated based on Euclidian distance using the dist function in R and the data 70 were hierarchically ordered using the hclust function in R. Next, the data were divided into n clusters in 71 decreased order of dendrogram height in 99 iterations with n ranging from 2 to 100 using the cutree function in to siNTC; all p-value annotations were calculated using a two-tailed paired student's t-test; NS = p-value > 0.05, 38 * = 0.05 < p-value < 0.005, ** = 0.005 < p-value < 0.0005, *** = p-value < 0.0005 39 40 Figure 3 : p38ß proviral mechanism is primarily STAT1-independent but leads to ISG expression as a byproduct 41 A) ACE2-A549 cells were transfected with siNTC, sip38ß, sip38δ, or siMSK2 in biological quadruplicate and 48h later infected with SARS-CoV-2 MOI 0.1 or mock-infected for 36h. Cells were then lysed and trypsin digested. A 43 fraction was saved for total protein abundance analysis and rest was subjected to phosphopeptide enrichment.

Mass spectrometry was performed using a DDA/DIA approach. Analysis was performed on raw data using 

Values represent the phosphosite group with the maximum Z-score transformed log2fold-change per substrate 40 protein in each data set. 47 Table S7 : Log2fold-changes, p-values, and adjusted p-values for differential expression results from mRNA-Seq 48 experiment; tabs specify conditions ( Figure 5 ). Daniloski, Z., Jordan, T.X., Wessels, H.H., Hoagland, D.A., Kasela, S., Legut, M., Maniatis, S., Mimitou, 03 E.P., Lu, L., Geller, E., et al. (2021) . Identification of Required Host Factors for SARS-CoV-2 Infection 04 in Human Cells. Cell 184, 92-105 e116. 05 Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, 06 M.L., Lescure, F.X., et al. (2020) . Compassionate Use of Remdesivir for Patients with Severe Covid-07 19. N Engl J Med 382, 2327 -2336 Group, R.C., Horby, P., Lim, W.S., Emberson, J.R., Mafham, M., Bell, J.L., Linsell, L., Staplin, N., 09 Brightling, C., Ustianowski, A., et al. (2020) . Dexamethasone in Hospitalized Patients with Covid-19 -10 Preliminary Report. N Engl J Med. Syndromes. Cell 184, 149-168 e117. 26 Kopecky-Bromberg, S.A., Martinez-Sobrido, L., and Palese, P. (2006) . 7a protein of severe acute 27 respiratory syndrome coronavirus inhibits cellular protein synthesis and activates p38 mitogen-28 activated protein kinase. J Virol 80, 785-793. 29 Lu, Y., Cai, H., Lu, M., Ma, Y., Li, A., Gao, Y., Zhou, J., Gu, H., Li, J., and Gu, J. (2020) N  MAP3K1  MAP3K2  MAP3K3  MAP3K4  MAP3K5  MAP3K6  MAP3K7  MAP3K8  MAP3K9  MAP3K10  MAP3K11  MAP3K12  TAOK1  TAOK2  TAOK3  MAP2K3  MAP2K4  MAP2K6 siRNA Target proteasomal ubiquitin−independent protein catabolic process proteasome core complex cytosolic large ribosomal subunit actin filament bundle assembly regulation of cellular amino acid metabolic process spliceosomal snRNP assembly regulation of hematopoietic stem cell differentiation (-) regulation of G2/M transition of mitotic cell cycle processing/presentation of exogenous antigen via MHC class I, TAP−dep import into nucleus antigen processing and presentation of antigen via MHC class I transport vesicle phagocytosis protein targeting to lysosome serine−type endopeptidase inhibitor activity receptor complex substrate adhesion−dependent cell spreading signaling receptor activity recycling endosome membrane specific granule membrane integrin−mediated signaling pathway phagocytic vesicle membrane (-) regulation of viral genome replication basement membrane integrin binding virus receptor activity animal organ morphogenesis cellular protein metabolic process collagen−containing extracellular matrix extracellular matrix organization interferon−gamma−mediated signaling pathway external side of plasma membrane response to virus (-) regulation of type I interferon production defense response to virus type I interferon signaling pathway 

Specific Mutations in the PB2 Protein 64 of Influenza A Virus Compensate for the Lack of Efficient Interferon Antagonism of the NS1 Protein of 65

Bat Influenza A-Like Viruses

Murine coronavirus replication-67 induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus 68 replication in cultured cells

Generation and characterization of p38beta (MAPK11) gene-71 targeted mice

p38beta Mitogen-Activated Protein Kinase Modulates Its Own Basal Activity 74 by Autophosphorylation of the Activating Residue Thr180 and the Inhibitory Residues

Multilevel proteomics reveals host perturbations by SARS-CoV-54 2 and SARS-CoV

Gene set enrichment analysis: a knowledge-57 based approach for interpreting genome-wide expression profiles

Nucleocapsid phosphorylation and RNA helicase DDX1 60 recruitment enables coronavirus transition from discontinuous to continuous transcription

Beltrao, P., Albanese, V., Kenner, L.R., Swaney, D.L., Burlingame, A., Villen, J., Lim, W.A., Fraser, 77 J.S., Frydman, J., and Krogan, N.J. (2012) . Systematic functional prioritization of protein 78 posttranslational modifications. Cell 150, 413-425. 79 Benjamini, Y., and Hochberg, Y. (1995) . Controlling the False Discovery Rate -a Practical and Powerful 80Approach to Multiple Testing. J R Stat Soc B 57, 289-300. 81 Bojkova, D., Klann, K., Koch, B., Widera, M., Krause, D., Ciesek, S., Cinatl, J., and Munch, C. (2020) . Figure 1